PubMed=9882297; DOI=10.1128/JVI.73.2.965-975.1999; PMCID=PMC103916
G. Habeshaw, Qing-Yun Yao, Andrew I. Bell, David Morton, Alan Bernard Rickinson;
Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.
J. Virol. 73:965-975(1999)

PubMed=12219084; DOI=10.1038/nm758
Gemma L. Kelly, Andrew I. Bell, Alan Bernard Rickinson;
Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Nat. Med. 8:1098-1104(2002)

PubMed=16051863; DOI=10.1128/JVI.79.16.10709-10717.2005; PMCID=PMC1182620
Gemma L. Kelly, Anne E. Milner, Rosemary J. Tierney, Debbie S.G. Croom-Carter, Markus Altmann, Wolfgang Hammerschmidt, Andrew I. Bell, Alan Bernard Rickinson;
Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
J. Virol. 79:10709-10717(2005)

PubMed=28960205; DOI=10.1038/cdd.2017.150; PMCID=PMC5762840
Leah Fitzsimmons, Andrew J. Boyce, Wen-Bin Wei, Catherine Chang, Debbie S.G. Croom-Carter, Rosemary J. Tierney, Marco J. Herold, Andrew I. Bell, Andreas Strasser, Gemma L. Kelly, Martin Rowe;
Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.
Cell Death Differ. 25:241-254(2018)